Krispy Kreme Inc
DNUT
$3.54 -0.56% Quote
Exchange NASDAQ Sector Consumer Defensive Industry Grocery Stores
Q3 2024
Reported
Published: Nov 8, 2024

Data: Financial Modeling Prep

Company Status Snapshot

Fast view of the latest quarter outcome for DNUT

Report Date

Nov 8, 2024

Quarter Q3 2024

Revenue

379.87M

YoY: -6.8%

EPS

0.23

YoY: +195.8%

Market Move

-0.56%

Previous quarter: Q2 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

Gross Margin

74.8%

Net Income

39.56M

YoY: +197.8%

We now expect the delighting Krispy Kreme fans with our melting of mouth doughnuts fresh daily in nearly 2,000 McDonald’s restaurants by the end of 2024.

— Josh Charlesworth
DNUT
Company DNUT

Swipe to view all report sections

Executive Summary

Krispy Kreme reported Q3 2024 net revenue of $379.9 million, down 6.75% year over year and 13.4% quarter over quarter, largely reflecting the July 2024 completion of the Insomnia Cookies divestiture and the seasonality of the period. Organic growth was 3.5% for the quarter, marking the 17th consecutive quarter of organic growth, driven by a 15% rise in Delivered Fresh Daily (DFD) and digital channels. The company disclosed a substantial strategic pivot toward a capital-light international footprint and a rapid U.S. expansion through McDonald’s, with the goal of making Krispy Kreme doughnuts available in roughly 12,000 McDonald’s locations by end-2026 and up to ~35,000 points of access globally within three years. Management highlighted the potential for $340–$430 million in annualized incremental revenue and $70–$100 million in incremental Adjusted EBITDA from the U.S. DFD initiative. In the near term, EBITDA margin compressed to 9.1% for the company as a whole, pressured by Insomnia Cookies divestiture-related effects, UK underperformance, and start-up costs associated with the McDonald’s rollout. Net income was $39.6 million, supported by $71.3 million of other income and a net positive contribution from the Insomnia Cookies transaction (net proceeds of $117.6 million and a $45 million loan repayment). The balance sheet shows meaningful leverage relief to about 3.9x post-divestiture, with liquidity modest (cash ~$25.9 million) and a plan to realize $8–$12 million of annualized SG&A savings beginning in 2025. The Q3 results set the stage for a sharper margin recovery in 2025 as U.S. DFD scale and hub-and-spoke efficiency drive operating leverage, offset by near-term start-up costs. Investors should monitor DFD execution, UK market recovery, and the timing of gross-margin expansion as manufacturing upgrades and route-density improvements mature.

Key Performance Indicators

Revenue
Decreasing
379.87M
QoQ: -13.43% | YoY: -6.75%
Gross Profit
Decreasing
284.03M
74.77% margin
QoQ: 238.70% | YoY: -7.18%
Operating Income
Decreasing
-16.00M
QoQ: -284.44% | YoY: -657.41%
Net Income
Increasing
39.56M
QoQ: 820.51% | YoY: 197.79%
EPS
Increasing
0.23
QoQ: 807.69% | YoY: 195.83%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 367.03 -0.13 -16.4% View
Q1 2025 375.18 -0.20 -15.3% View
Q4 2024 404.02 -0.13 -10.4% View
Q3 2024 379.87 0.23 -6.8% View
Q2 2024 438.81 -0.03 +7.7% View